Literature DB >> 17975810

Physicochemical, crystallographic, thermal, and spectroscopic behavior of crystalline and X-ray amorphous ciclesonide.

Martin Philipp Feth1, Jürgen Volz, Ursula Hess, Ernst Sturm, Rolf-Peter Hummel.   

Abstract

Single crystal structure experiments revealed that the orthorhombic needles of Ciclesonide crystallized in P2(1)2(1)2(1) space group with four independent molecules in the unit cell. Amorphous Ciclesonide was prepared by lyophilization and characterized in comparison with crystalline material by differential scanning calorimetry (DSC), Fourier transformed (FT)-Raman spectroscopy, powder X-ray diffraction, dissolution, and saturation solubility experiments. Significant differences in the dissolution, thermal, and spectrometric behavior were observed for both solid-state phases. DSC- and FT-Raman methods for the determination of amorphous content in crystalline Ciclesonide samples were established. Isothermal and dynamical recrystallization studies on amorphous Ciclesonide were conducted using dispersive hot-stage Raman microscopy. The recrystallization was observed to be a two-step process with an induction period (most likely nuclei formation) followed by the actual recrystallization (crystal growth). The recrystallization rate constants and Avrami exponents (n = 2) were determined from the isothermal experiments at various temperatures using Johnson-Mehl-Avrami theory. Isothermal activation energies were obtained from Arrhenius plots using the temperature dependence of (a) the rate constants (160.4 kJ/mol) and (b) the induction time (140.9 kJ/mol) of the isothermal hot-stage experiments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17975810     DOI: 10.1002/jps.21223

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  1 in total

1.  Quantitative Assessment of Pulmonary Targeting of Inhaled Corticosteroids Using Ex Vivo Receptor Binding Studies.

Authors:  Jie Shao; James Talton; Yaning Wang; Lawrence Winner; Guenther Hochhaus
Journal:  AAPS J       Date:  2020-01-30       Impact factor: 4.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.